Wound Care
Preclinical Research & Wound Care Device Testing
Wound care devices operate at the intersection of microbiology, host biology, and material science. These systems must perform in environments where microbial colonization, tissue response, and material interactions all influence outcomes.
Teams developing effective wound care devices and therapies require more than isolated testing; they require an integrated scientific evaluation across domains. iFyber supports wound care device developers through custom preclinical research, method development, and analysis designed to reflect real-world product performance.
The Challenge: Complexity Across Biological and Material Systems
Wound care technologies must address multiple, interconnected factors:
Microbial Colonization
Biofilm formation and microbial burden can influence wound healing outcomes and device performance.
Host Tissue Response
Inflammation, regeneration, and tissue compatibility all contribute to product performance.
Material Behavior
Leaching, material interactions, and functional properties must be evaluated under realistic conditions.
Traditional wound care device testing approaches often evaluate these factors in isolation, limiting their ability to predict real-world outcomes or explain product performance.
How iFyber Supports Wound Care Device Development
iFyber works as an extension of R&D teams, helping companies investigate complex questions and generate data that supports development, regulatory strategy, and marketing support. Support includes:
- Designing application-specific test methods and models
- Evaluating antimicrobial performance under realistic conditions
- Assessing biocompatibility and tissue response using relevant cell and tissue systems
- Characterizing materials and their interactions within biological environments using relevant extractable and leachable (E&L) techniques
- Generating data packages to support regulatory submissions, peer reviewed journal articles, and whitepapers
This approach enables teams to move beyond standardized test results toward product-relevant, decision-driving data.
Integrated Capabilities Across Wound Healing Science
Testing antimicrobial efficacy across planktonic and biofilm states, including barrier, direct contact, and time-kill studies.
Evaluation of biocompatibility, cytotoxicity, and healing response using cell cultures, human skin models, and ex vivo tissue models.
Assessment of wound care inflammatory markers across model systems to understand biological activity and therapeutic impact.
Characterization of materials, interfaces, and performance using analytical chemistry and materials science techniques.
Design of tailored assays and test systems that reflect the intended use and real-world conditions of the device.
Extending Into Clinical Sample Analysis
For programs advancing into clinical evaluation, iFyber can also support the analysis of clinical samples helping connect biological mechanisms observed preclinically with patient outcomes. Support includes:
- Study design input for quantifiable laboratory-based biological endpoints
- Sample collection strategy, kits, and handling protocols
- Integrated laboratory analysis across multiple methodologies
- Interpretation of results in the context of clinical outcomes
Beyond Standard CRO Testing
Standard CROs measure endpoints. iFyber helps uncover mechanisms.
510(k) Data Packages and Support
iFyber offers both standard and custom preclinical efficacy testing and data packages that can be submitted to FDA in support of substantial equivalence decisions for traditional medical devices and combination products, such as wound dressings and coated devices. iFyber has a GLP-compliant quality system and can provide GLP testing services upon request.
A Trusted, Global-Serving Contract Research Organization
Engage with iFyber’s Scientific Team
Connect with iFyber to explore how integrated preclinical research can support your wound care device development.